Table 1.
Clinical data of the patients
| Case | Age (y) | Sex | Days from admission until death | Days in ICU | Comorbidities | Clinical cause of death | Stage |
|---|---|---|---|---|---|---|---|
| COVID-19-1 | 78 | F | 1 (home care) | — | Cardiac pacemaker, obesity | Pneumonia | Vascular |
| COVID-19-2 | 50 | M | 9 | 8 | Bronchial asthma, peripheral pulmonary emphysema | Ventricular fibrillation | Vascular |
| COVID-19-3 | 59 | M | 12 | 8 | Arterial hypertension, intrinsic bronchial asthma | ARDS, multiorgan failure | Vascular |
| COVID-19-4 | 56 | M | 20 | 12 | Arterial hypertension | Multiorgan failure with progressive liver dystrophy | Epithelial |
| COVID-19-5 | 61 | M | 18 | 10 | Arterial hypertension | ARDS, multiorgan failure | Epithelial |
| COVID-19-6 | 58 | M | 21 | 8 | Diabetes type 2, obesity | ARDS | Epithelial |
| COVID-19-7 | 72 | M | 19 | 12 | NST EMI in 3-vessel disease | Multiorgan failure, acute liver dystrophy | Fibrotic |
| COVID-19-8 | 78 | M | 8 | 4 | Coronary artery disease, cardiomegaly, atherosclerosis | ARDS, multiorgan failure, liver hemophagocytosis | Fibrotic |
| COVID-19-9 | 74 | M | 32 | 15 | Coronary artery disease, pulmonary valve stenosis | Multiorgan failure with progressive liver dystrophy | Fibrotic |
| COVID-19-10 | 86 | F | 11 | 9 | Arterial hypertension | ARDS with progressive organization, pulmonary aspergillosis | Fibrotic |
ARDS, acute respiratory distress syndrome; F, female; M, male; NST EMI, non-ST-elevation myocardial infarction.